Copyright
©The Author(s) 2022.
World J Nephrol. Jul 25, 2022; 11(4): 127-138
Published online Jul 25, 2022. doi: 10.5527/wjn.v11.i4.127
Published online Jul 25, 2022. doi: 10.5527/wjn.v11.i4.127
Table 1 Clinical score parameters
Symptoms | Score | |
Scored as dehydration | Intradialytic hypotension | -1 |
Muscle cramps, dizziness or fatigue during current session of dialysis | -1 | |
Symptomatic dialysis hypotension treated by NaCl (0.9%) infusion | -1 | |
Scored as normohydration | Absence of symptoms given in this table | 0 |
Scored as fluid overload | Hypertension | +1 |
SPO2 less than 90% | +1 | |
Presence of ascites | +1 | |
Presence of pleural effusion or pulmonary oedema on clinical examination | +1 | |
Inter dialytic weight gain - per 1 kg gained | +1 | |
Presence of gallop rhythm | +2 | |
Dyspnoea based on NYHA class | 0 to +3 | |
Chest radiography features based on stage | +1 to +3 | |
Oedema (ankles, tibial, graded) | 0 to +4 |
Table 2 Demographic and clinical characteristics of study participants
Characteristic | Statistic | |
Age (yr) | Median (IQR) | 45 (20.5) |
Sex | Male, n (%) | 46 (57.5) |
CKD duration (mo) | Median (IQR) | 12.5 (24.5) |
Dialysis vintage | Median (IQR) | 9 (15) |
Blood pressure (mmHg) | Systolic mean ± SD | 150 ± 31 |
Diastolic mean ± SD | 91 ± 19 | |
Body mass index (kg/m2) | Median (IQR) | 21.94 (5.13) |
Comorbidities | Hypertension, n (%) | 41 (51.25) |
Glomerulonephritis, n (%) | 22 (27.5) | |
Diabetes mellitus, n (%) | 14 (17.5) | |
Obstructive uropathy, n (%) | 8 (10) | |
HIV, n (%) | 7 (8.75) | |
Malignancy, n (%) | 2 (2.5) | |
Graft failure post-transplant, n (%) | 2 (2.5) | |
Cystic kidney disease, n (%) | 1 (1.25) | |
Dialysis access | Arterio-venous fistula, n (%) | 26 (32.5) |
Clinical score | Hypovolemia, n (%) | 0 (0.00) |
Normovolemia, n (%) | 33 (41.25) | |
Hypervolemia, n (%) | 47 (58.25) | |
BIA | Dehydration, n (%) | 0 (0.00) |
Normal hydration, n (%) | 9 (11.25) | |
Fluid overload, n (%) | 71 (88.75) | |
Mild FO, n (%) | 25 (31.25) | |
Gross FO, n (%) | 46 (57.50) |
Table 3 2-by-2 table assessing association between bio-impedance analysis and the clinical score
Positive | Negative | Total | P value | 95%CI | ||
Clinical score | Positive | 45 | 2 | 47 | ||
Negative | 26 | 7 | 33 | |||
Total | 71 | 9 | 80 | |||
McNemar’s Chi Square (20.57) | < 0.0001 | 0.1758-0.4242 |
Table 4 Univariable analysis of factors associated with fluid overload
Variable | Values | FO+ (n = 71) | FO- (n = 9) | OR | 95%CI | P value |
Duration of dialysis1 (mo) | 3-76 | 71 | 9 | 1.05 | 0.967-1.147 | 0.13 |
No of missed dialysis sessions | 0 | 59 | 7 | |||
≥ 1 | 12 | 2 | 0.712 | 0.131-3.856 | 0.70 | |
Advised on fluid restriction | No | 6 | 2 | |||
Yes | 65 | 7 | 3.095 | 0.522-18.357 | 0.25 | |
Actual fluid intake1 (mL) | 200-2800 | 71 | 9 | 0.998 | 0.997-1.000 | 0.082 |
Advised on salt intake | No | 9 | 1 | |||
Yes | 62 | 8 | 0.8611 | 0.096-7.719 | 0.89 | |
Number of anti-hypertensives used | 0 | 11 | 0 | |||
1 | 13 | 2 | ||||
2 | 23 | 3 | ||||
3 | 14 | 4 | ||||
4 | 7 | 0 | ||||
5 | 2 | 0 | ||||
6 | 1 | 0 | 0.903 | 0.537-1.517 | 0.70 | |
Patient’s BMI1 (kg/m2) | 15.82-32.53 | 71 | 9 | 1.196 | 0.942-1.520 | 0.11 |
Table 5 Multivariable analysis of factors associated with fluid overload
- Citation: Muchiri K, Kayima JK, Ogola EN, McLigeyo S, Ndung’u SW, Kabinga SK. Concordance between bio-impedance analysis and clinical score in fluid-status assessment of maintenance haemodialysis patients: A single centre experience. World J Nephrol 2022; 11(4): 127-138
- URL: https://www.wjgnet.com/2220-6124/full/v11/i4/127.htm
- DOI: https://dx.doi.org/10.5527/wjn.v11.i4.127